Early detection of doxorubicin myocardial injury by ultrasonic tissue characterization in an experimental animal model

Cardiovascular Ultrasound

Volumn 10, Issue 1, 2012, Pages

  Romano, Minna Moreira Dias ^a   Pazin Filho, Antônio ^a   O'Connel, João Lucas ^a   Simões, Marcus Vinícius ^a   Schmidt, André ^a   Campos, Érica C ^a   Rossi, Marcos ^a   Maciel, Benedito Carlos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Doxorubicin; Echocardiography; Rats; Ultra sonic tissue characterization

Indexed keywords

COLLAGEN; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HISTOPATHOLOGY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PHANTOM; RAT; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DISEASE MODELS, ANIMAL; DOXORUBICIN; EARLY DIAGNOSIS; HEART DISEASES; MALE; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; VENTRICULAR FUNCTION, LEFT;

EID: 84867196891     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-10-40     Document Type: Article

References (29)

1. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Steinherz LJ, Graham T, Hurwitz R, Sondheimer HM, Schwartz RG, Shaffer EM, et al. Pediatrics 1992 89 5 Pt 1 942 949 1579408
2. Anthracycline-induced cardiotoxicity. Shan K, Lincoff AM, Young JB, Ann Intern Med 1996 125 1 47 58 8644988
3. Detection of myocardial dysfunction during cancer chemotherapy with tissue Doppler imaging: a canary in the coal mine? Hoit BD, J Am Soc Echocardiogr 2009 22 4 425 426 10.1016/j.echo.2009.02.010 19345310
4. Qualitative ultrasonic tissue characterization of the myocardium. Nicolosi GL, Lestuzzi C, Pavan D, Dall'Aglio V, Mimo R, Breda M, et al. J Nucl Med Allied Sci 1988 32 3 139 148 3066860
5. [Ultrasonic tissue characterization by spectral analysis of myocardial textural pattern]. Tatsukawa H, Furukawa K, Katsume H, Kosugi Y, Azuma A, Inoue N, et al. J Cardiol 1989 19 2 563 570 2636634
6. Myocardial ultrasonic tissue characterization in patients with different types of left ventricular hypertrophy: a videodensitometric approach. Zoni A, Regolisti G, Aschieri D, Borghetti A, J Am Soc Echocardiogr 1997 10 1 74 82 10.1016/S0894-7317(97)80036-3 9046497
7. [Ultrasonic tissue characterization analysis in type 1 diabetes: a very early index of diabetic cardiomyopathy?]. Di Bello V, Giampietro O, Matteucci E, Giorgi D, Bertini A, Piazza F, et al. G Ital Cardiol 1998 28 10 1128 1137 9834865
8. Ultrasonic tissue characterization for patients with Chagas' disease. Pazin-Filho A, Schmidt A, Almeida-Filho OC, Marin-Neto JA, Maciel BC, J Am Soc Echocardiogr 2004 17 3 262 268 10.1016/j.echo.2003.10.022 14981425
9. Quantitative ultrasonic tissue characterization with real-time integrated backscatter imaging in normal human subjects and in patients with dilated cardiomyopathy. Vered Z, Barzilai B, Mohr GA, Thomas LJ III, Genton R, Sobel BE, et al. Circulation 1987 76 5 1067 1073 10.1161/01.CIR.76.5.1067 3311450
10. Ultrasonic tissue characterization with integrated backscatter. Acute myocardial ischemia, reperfusion, and stunned myocardium in patients. Milunski MR, Mohr GA, Perez JE, Vered Z, Wear KA, Gessler CJ, et al. Circulation 1989 80 3 491 503 10.1161/01.CIR.80.3.491 2766504
11. Abnormal Ultrasonic Tissue Characterization of the Myocardium in Children Receiving Doxorubicin for Cancer Therapy. Bigras JL, McCrindle BW, Shibuya K, Smallhorn JF, Echocardiography 1998 15 2 121 126 10.1111/j.1540-8175.1998. tb00587.x 11175020
12. Early detection of doxorubicin-induced myocardial damage by ultrasound tissue characterization with integrated backscatter. Yokoyama N, Takeshita S, Kozuma K, Nishimura H, Chikuda I, Terakura M, et al. Circ J 2003 67 11 929 933 10.1253/circj.67.929 14578599
13. Detection of cardiomyopathic changes induced by doxorubicin based on quantitative analysis of ultrasonic backscatter. Mimbs JW, O'Donnell M, Miller JG, Sobel BE, Am J Cardiol 1981 47 5 1056 1060 10.1016/0002-9149(81)90212-5 7223651
14. [Echocardiography in mouse]. Fayssoil A, Ann Cardiol Angeiol (Paris) 2008 57 3 177 180 10.1016/j.ancard.2008.05.004
15. Problems in echocardiographic volume determinations: echocardiographic- angiographic correlations in the presence of absence of asynergy. Teichholz LE, Kreulen T, Herman MV, Gorlin R, Am J Cardiol 1976 37 1 7 11 10.1016/0002- 9149(76)90491-4 1244736
16. Preclinical animal models of cardiac protection from anthracycline- induced cardiotoxicity. Herman EH, Ferrans VJ, Semin Oncol 1998 25 4 Suppl 10 15 21 9768819
17. Serial assessment of myocardial properties using cyclic variation of integrated backscatter in an adriamycin-induced cardiomyopathy rat model. Ha JW, Kang SM, Pyun WB, Lee JY, Ahn MY, Kang WC, et al. Yonsei Med J 2005 46 1 73 77 10.3349/ymj.2005.46.1.73 15744808
18. [Drug-induced myocardial disease - adriamycin cardiotoxicity. Wakasugi S, Nippon Rinsho 2000 58 1 204 211 10885315
19. Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy. Wakasugi S, Fischman AJ, Babich JW, Callahan RJ, Elmaleh DR, Wilkinson R, et al. J Nucl Med 1993 34 9 1529 1535 8355075
20. Ultrasonic analysis of anthracycline-induced myocardial damage using cyclic variation of integrated backscatter. Nagai H, Omi W, Yuasa T, Sakagami S, Takata S, Kobayashi K, J Am Soc Echocardiogr 2003 16 8 808 813 10.1067/S0894-7317(03)00425-5 12878989
21. The extracellular matrix is an important source of ultrasound backscatter from myocardium. Hall CS, Scott MJ, Lanza GM, Miller JG, Wickline SA, J Acoust Soc Am 2000 107 1 612 619 10.1121/1.428327 10641669
22. Ultrasonic myocardial tissue characterization in patients with dilated cardiomyopathy: value in noninvasive assessment of myocardial fibrosis. Naito J, Masuyama T, Mano T, Kondo H, Yamamoto K, Nagano R, et al. Am Heart J 1996 131 1 115 121 10.1016/S0002-8703(96)90059-9 8553997
23. The variation of integrated backscatter in human hearts in differing ultrasonic transthoracic views. Lange A, Moran CM, Palka P, Fenn LN, Sutherland GR, McDicken WN, J Am Soc Echocardiogr 1995 8 6 830 838 10.1016/S0894-7317(05) 80007-0 8611283
24. Ultrasonic tissue characterization of end-stage dilated cardiomyopathy. Davison G, Hall CS, Miller JG, Scott M, Wickline SA, Ultrasound Med Biol 1995 21 7 853 860 10.1016/0301-5629(95)00036-Q 7491741
25. Ultrasound myocardial tissue characterization by integrated backscatter in children treated with anthracyclines. Goens MB, Karr SS, Seibel N, Martin GR, Pediatr Cardiol 1999 20 4 264 270 10.1007/s002469900461 10368451
26. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. Ganame J, Claus P, Uyttebroeck A, Renard M, D'hooge J, Bijnens B, et al. J Am Soc Echocardiogr 2007 20 12 1351 1358 10.1016/j.echo.2007.04.007 17604960
27. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. Jurcut R, Wildiers H, Ganame J, D'hooge J, De Backer J, Denys H, et al. J Am Soc Echocardiogr 2008 21 12 1283 1289 10.1016/j.echo.2008.10.005 19041569
28. Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough. Eidem BW, J Am Soc Echocardiogr 2008 21 12 1290 1292 10.1016/j.echo.2008.10.008 19041570
29. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy. Jassal DS, Han SY, Hans C, Sharma A, Fang T, Ahmadie R, et al. J Am Soc Echocardiogr 2009 22 4 418 424 10.1016/j.echo.2009.01.016 19269133